No abstract available
Keywords:
3D structure; cell therapy; cellular reprogramming; disease modeling; hiPSC; organoid.
Grants and funding
The authors were supported by funds from the National Institutes of Health [1R01NS115977 (LQ), R01NS104291 (MAL)], Department of Defense (GW160151), the CURE program via Drexel University College of Medicine (CURE Grant SAP Number: 4100083087), Pennsylvania Spinal Cord Injury Research Funds (LQ and MAL) SPF Foundation grant, and Moseley Foundation grant (LQ and MAL). CAD was supported by funding from the NIH (R01 DK124097, P30 DK26687). IF was supported by William P. Snyder, III Chair Endowment.